IL115384A - 2,7-Substituted octahydro-1h-pyrido [1,2-a]pyrazine derivatives and pharmaceutical compositions containing them - Google Patents
2,7-Substituted octahydro-1h-pyrido [1,2-a]pyrazine derivatives and pharmaceutical compositions containing themInfo
- Publication number
- IL115384A IL115384A IL11538495A IL11538495A IL115384A IL 115384 A IL115384 A IL 115384A IL 11538495 A IL11538495 A IL 11538495A IL 11538495 A IL11538495 A IL 11538495A IL 115384 A IL115384 A IL 115384A
- Authority
- IL
- Israel
- Prior art keywords
- pct
- pyrido
- pharmaceutical compositions
- compositions containing
- pyrazine derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Anesthesiology (AREA)
- Addiction (AREA)
- Ophthalmology & Optometry (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US31547094A | 1994-09-30 | 1994-09-30 |
Publications (2)
Publication Number | Publication Date |
---|---|
IL115384A0 IL115384A0 (en) | 1995-12-31 |
IL115384A true IL115384A (en) | 1999-10-28 |
Family
ID=23224581
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL11538495A IL115384A (en) | 1994-09-30 | 1995-09-21 | 2,7-Substituted octahydro-1h-pyrido [1,2-a]pyrazine derivatives and pharmaceutical compositions containing them |
Country Status (34)
Country | Link |
---|---|
US (1) | US5852031A (pt) |
EP (1) | EP0783503B1 (pt) |
JP (1) | JP3287574B2 (pt) |
KR (1) | KR100244848B1 (pt) |
CN (1) | CN1068327C (pt) |
AT (1) | ATE209648T1 (pt) |
AU (1) | AU681310B2 (pt) |
BR (1) | BR9504230A (pt) |
CA (1) | CA2200959C (pt) |
CO (1) | CO4410335A1 (pt) |
CZ (1) | CZ285090B6 (pt) |
DE (1) | DE69524241T2 (pt) |
DK (1) | DK0783503T3 (pt) |
ES (1) | ES2166830T3 (pt) |
FI (1) | FI113655B (pt) |
HR (1) | HRP950507B1 (pt) |
HU (1) | HUT77354A (pt) |
IL (1) | IL115384A (pt) |
MX (1) | MX9702350A (pt) |
MY (1) | MY113729A (pt) |
NO (1) | NO308995B1 (pt) |
NZ (1) | NZ290936A (pt) |
PE (1) | PE47196A1 (pt) |
PL (1) | PL180899B1 (pt) |
PT (1) | PT783503E (pt) |
RU (1) | RU2163239C2 (pt) |
SI (1) | SI9520096A (pt) |
SK (1) | SK284341B6 (pt) |
TR (1) | TR199501194A2 (pt) |
TW (1) | TW406081B (pt) |
UA (1) | UA50720C2 (pt) |
WO (1) | WO1996010571A1 (pt) |
YU (1) | YU63795A (pt) |
ZA (1) | ZA958223B (pt) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6231833B1 (en) | 1999-08-05 | 2001-05-15 | Pfizer Inc | 2,7-substituted octahydro-1H-pyrido[1,2-A]pyrazine derivatives as ligands for serotonin receptors |
US6992188B1 (en) | 1995-12-08 | 2006-01-31 | Pfizer, Inc. | Substituted heterocyclic derivatives |
WO1997023482A1 (en) * | 1995-12-21 | 1997-07-03 | Pfizer Inc. | 2,7-substituted octahydro-pyrrolo[1,2-a]pyrazine derivatives |
US6281216B1 (en) * | 1998-02-09 | 2001-08-28 | Duphar International Research B.V. | 2-aminoquinoline derivatives having d4-agonistic activity |
EP0953567A3 (en) | 1998-04-29 | 2003-04-02 | Pfizer Products Inc. | Bicyclic substituted piperazine-, piperidine- and tetrahydropyridine derivatives, their preparation and their use as agents with central dopaminergic (dopamine D4 receptor) activity |
GT199900060A (es) * | 1998-05-22 | 2000-10-14 | Polimorfos de un monoclorhidrato de pirazina cristalino y sus composiciones farmacèuticas. | |
GB0010757D0 (en) | 2000-05-05 | 2000-06-28 | Astrazeneca Ab | Chemical compounds |
GB0011013D0 (en) * | 2000-05-09 | 2000-06-28 | Astrazeneca Ab | Chemical compounds |
EP1177792A3 (en) | 2000-07-27 | 2002-10-23 | Pfizer Products Inc. | Dopamine D4 Ligands for the treatment of novelty-seeking disorders |
US6670476B2 (en) | 2000-11-29 | 2003-12-30 | Pfizer Inc. | Resolution of trans-7-(hydroxy-methyl)octa-hydro-2H-pyrido[1,2-a]pyrazine |
GB0121941D0 (en) | 2001-09-11 | 2001-10-31 | Astrazeneca Ab | Chemical compounds |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3388128A (en) * | 1965-09-03 | 1968-06-11 | Allan R. Day | Substituted 1, 4-diazabicyclo [4. 4. 9] decanes |
US4182763A (en) * | 1978-05-22 | 1980-01-08 | Mead Johnson & Company | Buspirone anti-anxiety method |
US4517187A (en) * | 1982-10-18 | 1985-05-14 | Pennwalt Corporation | 1,3,4,6,7-11b-Hexahydro-7-phenyl-2H-pyrazino[2,1-a]isoquinolines methods of preparation, and use as antidepressants |
EP0173634B1 (fr) * | 1984-08-07 | 1988-08-31 | Cortial S.A. | Nouveaux dérivés d'(arylpipérazinyléthylaminoéthoxy)-4 phénol, leur méthode de préparation et leur application thérapeutique |
US4704390A (en) * | 1986-02-13 | 1987-11-03 | Warner-Lambert Company | Phenyl and heterocyclic tetrahydropyridyl alkoxy-benzheterocyclic compounds as antipsychotic agents |
IT1204803B (it) * | 1986-02-17 | 1989-03-10 | Acraf | Composto farmacologicamente attivo e composizioni farmaceutiche che lo contengono,procedimento per prepararlo e intermedio utile in detto procedimento |
US4788290A (en) * | 1987-12-11 | 1988-11-29 | American Home Products Corporation | Serotonergic pyrazine derivatives |
SE8803429D0 (sv) * | 1988-09-28 | 1988-09-28 | Pharmacia Ab | Novel pyridyl- and pyrimidyl derivatives |
WO1990008148A1 (en) * | 1989-01-23 | 1990-07-26 | Pfizer Inc. | Bis-aza-bicyclic anxiolytic agents |
DE69108743T2 (de) * | 1991-01-31 | 1995-08-17 | Pfizer | Recematspaltung von trans-2-(2-pyrimidinyl)-7-(hydroxymethyl)octahydro-2h-pyrido[1,2-a]-pyrazin. |
US5185449A (en) * | 1991-02-27 | 1993-02-09 | Pfizer Inc. | Process and intermediate for certain bis-aza-bicyclic anxiolytic agents |
CA2101252C (en) * | 1991-02-27 | 1998-02-17 | Frank J. Urban | Process for preparing trans-piperidine-2,5- dicarboxylates |
US5157034A (en) * | 1991-02-27 | 1992-10-20 | Pfizer Inc. | Neuroleptic perhydro-1H-pyrido[1,2-a]pyrazines |
ES2096099T3 (es) * | 1991-09-25 | 1997-03-01 | Pfizer | Perhidro-1h-pirido(1,2,a)pirazinas 2-sustituidas neurolepticas. |
EP0646116B1 (en) * | 1992-06-16 | 1999-10-13 | Pfizer Inc. | Process and intermediates for bis-aza-bicyclic anxiolytic agents |
US5670522A (en) * | 1992-10-23 | 1997-09-23 | Merck Sharp & Dohme Limited | Dopamine receptor subtype ligands |
EP0665833B1 (en) * | 1992-10-23 | 1999-07-14 | MERCK SHARP & DOHME LTD. | Dopamine receptor subtype ligands |
AU679040B2 (en) * | 1993-03-01 | 1997-06-19 | Merck Sharp & Dohme Limited | Pyrrolo-pyridine derivatives as dopamine receptor ligands |
CZ224195A3 (en) * | 1993-03-01 | 1996-03-13 | Merck Sharp & Dohme | The use of pyrrolopyridine derivatives for preparing pharmaceutical preparations |
US5576319A (en) * | 1993-03-01 | 1996-11-19 | Merck, Sharp & Dohme Ltd. | Pyrrolo-pyridine derivatives |
CA2156409A1 (en) * | 1993-03-05 | 1994-09-15 | Janusz Jozef Kulagowski | Quinolone derivatives as dopamine d4 ligands |
GB9416162D0 (en) * | 1994-08-10 | 1994-09-28 | Merck Sharp & Dohme | Therapeutic agents |
-
1995
- 1995-08-24 CN CN95195356A patent/CN1068327C/zh not_active Expired - Fee Related
- 1995-08-24 CZ CZ97947A patent/CZ285090B6/cs not_active IP Right Cessation
- 1995-08-24 AU AU31893/95A patent/AU681310B2/en not_active Ceased
- 1995-08-24 SI SI9520096A patent/SI9520096A/sl not_active IP Right Cessation
- 1995-08-24 WO PCT/IB1995/000689 patent/WO1996010571A1/en active IP Right Grant
- 1995-08-24 US US08/809,145 patent/US5852031A/en not_active Expired - Lifetime
- 1995-08-24 PT PT95927915T patent/PT783503E/pt unknown
- 1995-08-24 DE DE69524241T patent/DE69524241T2/de not_active Expired - Lifetime
- 1995-08-24 SK SK325-97A patent/SK284341B6/sk unknown
- 1995-08-24 JP JP51155196A patent/JP3287574B2/ja not_active Expired - Lifetime
- 1995-08-24 NZ NZ290936A patent/NZ290936A/en unknown
- 1995-08-24 EP EP95927915A patent/EP0783503B1/en not_active Expired - Lifetime
- 1995-08-24 PL PL95319636A patent/PL180899B1/pl not_active IP Right Cessation
- 1995-08-24 HU HU9702037A patent/HUT77354A/hu unknown
- 1995-08-24 CA CA002200959A patent/CA2200959C/en not_active Expired - Fee Related
- 1995-08-24 UA UA97031431A patent/UA50720C2/uk unknown
- 1995-08-24 KR KR1019970702080A patent/KR100244848B1/ko not_active IP Right Cessation
- 1995-08-24 RU RU97105362/04A patent/RU2163239C2/ru not_active IP Right Cessation
- 1995-08-24 MX MX9702350A patent/MX9702350A/es unknown
- 1995-08-24 DK DK95927915T patent/DK0783503T3/da active
- 1995-08-24 AT AT95927915T patent/ATE209648T1/de not_active IP Right Cessation
- 1995-08-24 ES ES95927915T patent/ES2166830T3/es not_active Expired - Lifetime
- 1995-09-18 TW TW084109759A patent/TW406081B/zh not_active IP Right Cessation
- 1995-09-21 IL IL11538495A patent/IL115384A/xx active IP Right Grant
- 1995-09-25 MY MYPI95002850A patent/MY113729A/en unknown
- 1995-09-26 PE PE1995279990A patent/PE47196A1/es not_active Application Discontinuation
- 1995-09-28 CO CO95045095A patent/CO4410335A1/es unknown
- 1995-09-29 ZA ZA958223A patent/ZA958223B/xx unknown
- 1995-09-29 YU YU63795A patent/YU63795A/sh unknown
- 1995-09-29 BR BR9504230A patent/BR9504230A/pt not_active IP Right Cessation
- 1995-09-29 TR TR95/01194A patent/TR199501194A2/xx unknown
- 1995-09-29 HR HR950507A patent/HRP950507B1/xx not_active IP Right Cessation
-
1997
- 1997-03-25 NO NO971416A patent/NO308995B1/no unknown
- 1997-03-27 FI FI971310A patent/FI113655B/fi not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
YU40300A (sh) | Aril fuzirana azapoliciklična jedinjenja | |
GEP20033081B (en) | Pharmaceutical Agents for Treatment of Parkinson's Disease, ADFD and Microadenomas | |
IL115384A (en) | 2,7-Substituted octahydro-1h-pyrido [1,2-a]pyrazine derivatives and pharmaceutical compositions containing them | |
GR3019490T3 (en) | Substituted piperazines as central nervous system agents | |
HUP0003118A2 (hu) | 2,7-Szubsztituált oktahidro-1H-pirido-[1,2-a]pirazin-származékok alkalmazása gyógyszerkészítmények előállítására | |
IL124966A0 (en) | 1-indanyl- and 1-indanylidene-acetic derivatives | |
HUT50325A (en) | Process for producing bisphenylalkyl piperazine derivatives and pharmaceutical compositions comprising same as active ingredient | |
GB9318691D0 (en) | Therapeutic agents | |
IL100458A0 (en) | Pharmaceutical compositions containing antagonists of the quisqualate receptor | |
AU693241B2 (en) | New 3-substituted 3h-2,3-benzodiazepine derivatives, their preparation and use as medicaments | |
MY130757A (en) | Bicyclic compounds and their use in medicine, process for their preparation and pharmaceutical compositions containing them | |
EP0233483A3 (en) | Pyrroloû1,2-a¨û4,1¨benzoxazepines, process for their preparation, pharmaceutical compositions containing these compounds and therapeutical use | |
ZA955941B (en) | Derivatives of imidazo(1,2-a)indeno(1,2-e)pyrazine-2-carboxylic acid their preparation and medicaments containing them | |
ZA9480B (en) | Pyrrolidine derivatives their preparation and medicaments containing them | |
PL311296A1 (en) | Derivatives of benzo [f] quinoxalinodione, method of obtaining them and their application in therapeutic agents | |
IL100128A0 (en) | Pharmaceutical compositions containing an imidazobenzodiazepine | |
MX9705390A (es) | Uso de los 3,4-difenil-cromanos para la fabricacion de una composicion farmaceutica para el tratamiento o profilaxis de desordenes degenerativos cerebrales. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FF | Patent granted | ||
KB | Patent renewed | ||
KB | Patent renewed |